PD-Rx Pharmaceuticals, Inc. recalls Glimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: PD-Rx Pharmaceuticals Incorporated Oklaho
Recalled May 10, 2023 · FDA recall D-0559-2023 · PD-Rx Pharmaceuticals
Hazard
CGMP deviations. · FDA Class II
Units
186 bottles
Sold at
Nationwide in the US.
Description
CGMP deviations.
Product
Glimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127, NDC 43063-0587-90
Manufacturer(s)
PD-Rx Pharmaceuticals, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →